oncobell, autor en ONCOBELL

10/30/2018

Oncobell Symposium 2018: Joan Seoane Interview

Joan Seoane from Vall D'Hebron Instituto de Oncología (VHIO, Spain) summarizes his paper at the Oncobell Symposium 2018.

10/25/2018

Oncobell Symposium 2018: Douglas Hanahan Interview

Douglas Hanahan from Swiss Institute for Experimental Cancer Research (ISREC, Switzerland) summarizes his paper at the Oncobell Symposium 2018.

10/17/2018

Oncobell Symposium 2018: Eduard Batlle Interview

Eduard Batlle from Institute for Research in Biomedicine summarizes his paper at the Oncobell Symposium 2018.

10/15/2018

Oncobell Symposium 2018: Mark Rubin Interview

Mark Rubin from Bern University (Switzerland) summarizes his paper at the Oncobell Symposium 2018.

10/11/2018

Oncobell Symposium 2018: Manel Juan Interview

Manel Juan from Hospital Clínic summarizes his paper at the Oncobell Symposium 2018.

10/08/2018

Oncobell Symposium 2018: Alena Gros Interview

Alena Gros from Vall d'Hebrón Instituto de Oncología (VHIO) summarizes her paper at the Oncobell Symposium 2018.

10/04/2018

Oncobell Symposium 2018: Eva Domingo-Domènech Interview

Eva Domingo-Domènech from IDIBELL summarizes her paper at the Oncobell Symposium 2018.

10/01/2018

Oncobell Symposium: René Bernards Interview

René Bernards from Netherlands Cancer Institute summarizes his paper at the Oncobell Symposium 2018.

09/18/2018

Francesc Viñals, group leader of Molecular Signaling in Cancer Group, talks about his cancer research

Francesc Viñals is the group leader of Molecular signaling in cancer"group in Oncobell. The molecular signalling cascades which are produced at the cell level are essential for responding to changes in its environment or to alter its homeostasis, e.g. at the cell proliferation, movement, growth or metabolism levels. Understanding the mechanism of signal transduction enables…

09/12/2018

Ramon Alemany, group leader of Cancer Virotherapy Group, talks about his research and lecture

Ramon Alemany is the leader of the Cancer Virotherapy Group in Oncobell, which explores new anticancer treatments based on oncolytic adenoviruses. The group aims to design and evaluate oncolytic adenoviruses as antitumour agents for various solid tumours. The main lines of research are tumour targets, intratumoural diffusion through stromal barriers and oncolytic immunotherapy. The group…